306 related articles for article (PubMed ID: 24462443)
1. Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis.
Mihara T; Kakeya H; Izumikawa K; Obata Y; Nishino T; Takazono T; Kosai K; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Tsukamoto M; Yamamoto Y; Yanagihara K; Tashiro T; Kohno S
J Infect Chemother; 2014 Feb; 20(2):104-8. PubMed ID: 24462443
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.
Lewis RE; Albert ND; Liao G; Hou J; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2010 Mar; 54(3):1298-304. PubMed ID: 20038620
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
5. High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia.
Lewis RE; Albert NP; Liao G; Wang W; Prince RA; Kontoyiannis DP
J Antimicrob Chemother; 2013 May; 68(5):1148-51. PubMed ID: 23349440
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model.
Takemoto K; Yamamoto Y; Kanazawa K
J Infect Chemother; 2010 Dec; 16(6):388-95. PubMed ID: 20535522
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial.
Slobbe L; Boersma E; Rijnders BJ
Pulm Pharmacol Ther; 2008 Dec; 21(6):855-9. PubMed ID: 18951992
[TBL] [Abstract][Full Text] [Related]
9. Disposition of aerosolized liposomal amphotericin B.
Lambros MP; Bourne DW; Abbas SA; Johnson DL
J Pharm Sci; 1997 Sep; 86(9):1066-9. PubMed ID: 9294824
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
Kirkpatrick WR; Najvar LK; Vallor AC; Wiederhold NP; Bocanegra R; Pfeiffer J; Perkins K; Kugler AR; Sweeney TD; Patterson TF
J Antimicrob Chemother; 2012 Apr; 67(4):970-6. PubMed ID: 22240402
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary mucormycosis: benefit of aerosol amphotericin B?].
Furco A; Mouchet B; Carbonnelle M; Vallerand H
Rev Mal Respir; 2001 Jun; 18(3):309-13. PubMed ID: 11468594
[TBL] [Abstract][Full Text] [Related]
12. Aerosolised liposomal amphotericin B to prevent aspergillosis in acute myeloid leukaemia: Efficacy and cost effectiveness in real-life.
Chong GL; Broekman F; Polinder S; Doorduijn JK; Lugtenburg PJ; Verbon A; Cornelissen JJ; Rijnders BJ
Int J Antimicrob Agents; 2015 Jul; 46(1):82-7. PubMed ID: 25956843
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis.
Gebremariam T; Gu Y; Singh S; Kitt TM; Ibrahim AS
J Antimicrob Chemother; 2021 Sep; 76(10):2636-2639. PubMed ID: 34263306
[TBL] [Abstract][Full Text] [Related]
14. Posaconazole prophylaxis in experimental systemic zygomycosis.
Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Pisa E; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2007 Jan; 51(1):73-7. PubMed ID: 17060525
[TBL] [Abstract][Full Text] [Related]
15. Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
Takemoto K; Yamamoto Y; Ueda Y; Kanazawa K; Yoshida K; Niki Y
Chemotherapy; 2009; 55(2):105-13. PubMed ID: 19151551
[TBL] [Abstract][Full Text] [Related]
16. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study.
Lowry CM; Marty FM; Vargas SO; Lee JT; Fiumara K; Deykin A; Baden LR
Transpl Infect Dis; 2007 Jun; 9(2):121-5. PubMed ID: 17461997
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation.
BitMansour A; Brown JM
J Infect Dis; 2002 Jul; 186(1):134-7. PubMed ID: 12089676
[TBL] [Abstract][Full Text] [Related]
18. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae.
Ibrahim AS; Avanessian V; Spellberg B; Edwards JE
Antimicrob Agents Chemother; 2003 Oct; 47(10):3343-4. PubMed ID: 14506054
[TBL] [Abstract][Full Text] [Related]
19. Aerosolized liposomal amphotericin B: prediction of lung deposition, in vitro uptake and cytotoxicity.
Fauvel M; Farrugia C; Tsapis N; Gueutin C; Cabaret O; Bories C; Bretagne S; Barratt G
Int J Pharm; 2012 Oct; 436(1-2):106-10. PubMed ID: 22814222
[TBL] [Abstract][Full Text] [Related]
20. Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B.
Smith PJ; Olson JA; Constable D; Schwartz J; Proffitt RT; Adler-Moore JP
J Antimicrob Chemother; 2007 May; 59(5):941-51. PubMed ID: 17400589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
